Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Other Accumulated Expenses (2016 - 2025)

InspireMD (NSPR) has 11 years of Other Accumulated Expenses data on record, last reported at $269000.0 in Q3 2025.

  • For Q3 2025, Other Accumulated Expenses rose 44.62% year-over-year to $269000.0; the TTM value through Sep 2025 reached $269000.0, up 44.62%, while the annual FY2024 figure was $255000.0, 34.21% up from the prior year.
  • Other Accumulated Expenses reached $269000.0 in Q3 2025 per NSPR's latest filing, up from $241000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $269000.0 in Q3 2025 and bottomed at $83000.0 in Q3 2021.
  • Average Other Accumulated Expenses over 5 years is $160473.7, with a median of $155000.0 recorded in 2021.
  • Peak YoY movement for Other Accumulated Expenses: skyrocketed 184.09% in 2021, then fell 29.41% in 2022.
  • A 5-year view of Other Accumulated Expenses shows it stood at $155000.0 in 2021, then decreased by 16.13% to $130000.0 in 2022, then surged by 46.15% to $190000.0 in 2023, then skyrocketed by 34.21% to $255000.0 in 2024, then rose by 5.49% to $269000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $269000.0 in Q3 2025, $241000.0 in Q2 2025, and $217000.0 in Q1 2025.